3 completed, 1 active not recruiting. 2 Phase 1, 2 Phase 2, 1 Not applicable.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 2 | Active not recruiting 1, Completed 1 |
| Phase 2 | 2 | Completed 2 |
| Not applicable | 1 | Completed 1 |
Follow Unresectable Esophageal Carcinoma: new trials by email Literature Review of Unresectable Esophageal Carcinoma trials Research Report on Unresectable Esophageal Carcinoma
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Testing the Addition of an Anti-cancer Drug, Adavosertib, to Radiation Therapy for Patients With Incurable Esophageal and Gastroesophageal Junction Cancers Adavosertib, Radiation Therapy - Clinical Stage III Esophageal Adenocarcinoma AJCC v8, Clinical Stage III Esophageal Squamous Cell Carcinoma AJCC v8 | Phase 1 | Active not recruiting | National Cancer Institute (NCI) | 4 | 2021-04-09 | 2026-07-31 |
| Effects on Quality of Life With Zinc Supplementation in Patients With Gastrointestinal Cancer Zinc - Gastric Carcinoma, Liver and Intrahepatic Bile Duct Carcinoma | Not applicable | Completed | Emory University | 17 | 2019-04-17 | 2025-10-09 |
| Olaparib and Ramucirumab in Treating Patients With Metastatic or Locally Recurrent Gastric or Gastroesophageal Junction Cancer That Cannot Be Removed by Surgery Olaparib, Ramucirumab - Metastatic Esophageal Carcinoma, Metastatic Gastric Carcinoma | Phase 1 / Phase 2 | Completed | National Cancer Institute (NCI) | 51 | 2018-02-06 | 2026-02-03 |
| Epacadostat and Pembrolizumab in Treating Patients With Metastatic or Unresectable Gastroesophageal Junction or Gastric Cancer Epacadostat, Pembrolizumab - Gastric Adenocarcinoma, Gastroesophageal Junction Adenocarcinoma | Phase 2 | Completed | George Albert Fisher | 3 | 2017-09-13 | 2024-01-23 |
Stomach Neoplasms (3) · Esophageal Neoplasms (2) · Adenocarcinoma Of Esophagus (1) · Brain Neoplasms (1) · Carcinoma, Hepatocellular (1) · Esophageal Squamous Cell Carcinoma (1) · Meningeal Carcinomatosis (1)
Digestive System Diseases (4) · Digestive System Neoplasms (4) · Gastrointestinal Diseases (4) · Gastrointestinal Neoplasms (4) · Neoplasms (4) · Neoplasms by Site (4) · Esophageal Diseases (3) · Head and Neck Neoplasms (3) · Stomach Diseases (3) · Carcinoma (2) · Neoplasms by Histologic Type (2) · Neoplasms, Glandular and Epithelial (2) · Adenocarcinoma (1) · Brain Diseases (1) · Carcinoma, Squamous Cell (1)
Radiation (1) · Radiotherapy (1) · Ramucirumab (1) · Zinc (1) · Zinc Sulfate (1) · adavosertib (1) · epacadostat (1) · olaparib (1) · pembrolizumab (1)
National Cancer Institute (NCI) (2) · Emory University (1) · George Albert Fisher (1)
United States (4)
Eric D Miller (1) · George A Fisher, MD (1) · Michael Cecchini (1) · Olatunji B. Alese, MD (1)
P30CA138292 (1), UM1CA186689 (1), UM1CA186712 (1)